Baseline clinical characteristics
| Age (years) | 46±19 |
| Sex | |
| Male | 36 (41.4%) |
| Female | 51 (58.6%) |
| Laterality | |
| Unilateral | 5 (5.7%) |
| Bilateral | 82 (94.3%) |
| BCVA (decimal Snellen) | 0.9±0.5 |
| Baseline treatment | |
| Disease-modifying antirheumatic drugs | 45 (51.1%) |
| Associated systemic disease/aetiology | |
| Sarcoidosis | 20 (12.2%) |
| Latent tuberculosis | 8 (4.9%) |
| Behçet | 24 (14.6%) |
| Idiopathic | 112 (71.8%) |
| SS-OCT findings | |
| Epiretinal membrane | 53 (34%) |
| Cystoid macular oedema | 28 (18%) |
BCVA, best-corrected visual acuity; SS-OCT, swept-source optical coherence tomography.